Back
Range Cancer Therapeutics ETF Vs. Novartis AG Industry Stock Comparison
Sell
12
CNCR
Range Cancer Therapeutics ETF
Last Price:
$11.00
Seasonality Move:
-3.32%
Buy
62
NVSEF
Novartis AG
Last Price:
$109.00
Seasonality Move:
5.79%
Sell
12
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
-
The current Range Cancer Therapeutics ETF [CNCR] share price is $10.93. The Score for CNCR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
CNCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $109.00. The Score for NVSEF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $10.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $109.00The current trend is moderately bearish and NVSEF is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 38.23 | Sell |
Chaikin Money Flow: | 171 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.17 - 12.55) | Sell |
Bollinger Bands (100): | (11.79 - 14.53) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.7 | Buy |
Relative Strength Index (14 RSI): | 49.51 | Sell |
Chaikin Money Flow: | 5487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.67 - 112.23) | Buy |
Bollinger Bands (100): | (98.63 - 109.37) | Buy |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11 | Sell |
20-day SMA: | 11.72 | Sell |
50-day SMA: | 12.06 | Sell |
200-day SMA: | 13.89 | Sell |
8-day EMA: | 11.1 | Sell |
20-day EMA: | 11.52 | Sell |
50-day EMA: | 12.12 | Sell |
200-day EMA: | 13.43 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.29 | Sell |
20-day SMA: | 109.25 | Sell |
50-day SMA: | 103.73 | Buy |
200-day SMA: | 106.3 | Buy |
8-day EMA: | 112.15 | Sell |
20-day EMA: | 109.66 | Sell |
50-day EMA: | 106.19 | Buy |
200-day EMA: | 104.21 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |